21 Apr 2026
AMEND USA participating in two spring medical conferences: Endocrine Surgery and Society of Nuclear Medicine
AMEND USA is proud to announce that board members John Metzcar (AMEND USA President) and Thomas Lehrich are actively engaging in patient advocacy this spring by participating in two leading medical meetings: the AAES Annual Meeting in Lexington Kentucky and the SNMMI Annual Meetin in Los Angeles.
These important gatherings bring together experts, clinicians, researchers, and industry leaders who are shaping the future of care for patients with endocrine and neuroendocrine conditions. By participating at both meetings, AMEND USA continues its commitment to ensuring that the patient voice is represented in conversations that influence research, treatment, and clinical practice.
The AAES Annual Meeting is dedicated to advancing the science and innovation in endocrine surgery through knowledge exchange, collaboration, and community. The 2026 meeting promises innovative programming, valuable networking opportunities, and scholarly enrichment all designed to strengthen the professional connections that drive progress in the field.
The 2026 SNMMI Annual Meeting will highlight groundbreaking research and clinical innovation in nuclear medicine and molecular imaging. This critical event unites physicians, technologists, pharmacists, laboratory professionals, scientists, and industry leaders to showcase cutting-edge developments that are accelerating the path toward better patient care.
Through participation in these meetings, AMEND USA board members will advocate for the needs and perspectives of patients, foster collaboration with the medical community, and stay informed on the latest advancements that impact the endocrine and neuroendocrine disease landscape.AMEND USA remains dedicated to empowering patients, supporting education, and building partnerships that improve outcomes and quality of life for those we serve.